Company record
Cangene BioPharma, LLC dba Emergent BioSolutions
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Cangene BioPharma, LLC dba Emergent BioSolutions.
Warning letters
-
DrugsCangene BioPharma, LLC dba Emergent BioSolutions
FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.
High risk